AirSculpt Technologies, Inc.

AIRS ·Healthcare, Medical Care Facilities, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Operating Activities
Net Income $-11.7M $-8.0M $-4.2M $-14.7M $10.6M $7.6M $-2.2M
Depreciation & Amortization $12.8M $11.9M $10.3M $8.1M $6.6M $5.6M $5.0M
Depreciation $8.0M $7.1M $5.5M $3.3M $1.8M $900.0K $200.0K
Amortization $4.8M $4.8M $4.8M $4.8M $4.8M $4.8M $4.8M
Stock-Based Compensation $2.3M $3.8M $18.2M $29.5M $7.2M $325.0K $341.0K
Net Cash from Operating Activities $3.1M $11.4M $24.0M $24.4M $26.6M $14.0M $4.9M
Investing Activities
Capital Expenditures $2.4M $14.0M $9.9M $12.9M $7.1M $3.7M $4.4M
Business Acquisitions — — — — — — —
Net Cash from Investing Activities $-2.4M $-14.0M $-9.9M $-12.9M $-7.1M $-3.7M $-4.4M
Financing Activities
Dividends Paid $0 $252.0K $385.0K $23.2M $0 $0 —
Stock Repurchases — — — — — — —
Net Cash from Financing Activities $-478.0K $630.0K $-13.4M $-27.3M $-4.5M $-5.0M $-783.0K
Net Change in Cash $214.0K $-2.0M $646.0K $-15.7M $15.0M $5.3M $-284.0K
Free Cash Flow $692.0K $-2.7M $14.0M $11.5M $19.5M $10.3M $499.0K